What Is Chronic Fatigue Syndrome?
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) is a complex medical condition characterized by profound and disabling fatigue that does not improve with rest and worsens significantly after physical or mental exertion. It is not simple "tiredness" — it is a multisystem disease that affects the neurological, immunological, and energy systems.
ME/CFS is one of the most misunderstood and stigmatized medical conditions. For decades, it was considered "psychological" or "imaginary." Today, growing research suggests objective biological abnormalities — findings of mitochondrial dysfunction, immune dysregulation, dysautonomia, and brain changes — that point to an organic basis, although the precise causal mechanisms remain under investigation.
The condition gained renewed attention during the COVID-19 pandemic, as many patients with "long COVID" develop a picture indistinguishable from ME/CFS. This reinforced the infectious-trigger hypothesis and accelerated research on the condition.
Post-Exertional Malaise
The most characteristic symptom: significant worsening of all symptoms after minimal physical or mental effort, with recovery taking days to weeks.
Biological Disease
Studies show mitochondrial dysfunction, chronic immune activation, dysautonomia, and metabolic changes — this is not a psychological condition.
Severe Impact
25% of patients become housebound or bedbound. Quality of life in ME/CFS is comparable to or worse than in heart failure or multiple sclerosis.
Pathophysiology
ME/CFS is a multisystem disease whose pathophysiology involves multiple interrelated mechanisms. The current model suggests that a trigger (often infectious) sets off a cascade of immunological, metabolic, and neurological dysfunctions that self-perpetuate.
Immunological Dysfunction
Patients with ME/CFS present chronic low-grade immune activation with a pro-inflammatory profile. There is an increase in inflammatory cytokines (IL-6, TNF-alpha), dysfunction of NK (natural killer) cells, and evidence of autoimmunity. Many cases are preceded by viral infections (EBV, enteroviruses, COVID-19) that appear to trigger a persistent dysregulated immune response.
Mitochondrial and Metabolic Dysfunction
Mitochondria — the "power plants" of cells — appear to function deficiently in ME/CFS. Metabolomic studies suggest alterations in cellular energy metabolism, with findings of reduced oxidative phosphorylation, lactate accumulation, and greater dependence on anaerobic metabolism in submaximal efforts. These findings are consistent with the disproportionate exhaustion reported by patients, although the direct causal relationship remains under investigation.
Dysautonomia
The majority of patients present autonomic nervous system dysfunction. Postural orthostatic tachycardia (POTS) — excessive increase in heart rate on standing — is found in up to 70% of patients. Dysautonomia contributes to orthostatic intolerance, dizziness, palpitations, and worsening of symptoms when remaining upright.
Symptoms
ME/CFS presents a wide spectrum of symptoms that varies between patients and fluctuates over time. The pathognomonic symptom — which distinguishes ME/CFS from other causes of fatigue — is post-exertional malaise.
Symptoms of ME/CFS
- 01
Profound and disabling fatigue
Fatigue that substantially reduces (>50%) the pré-illness activity level. Does not improve with rest. Present for at least 6 months. Qualitatively different from "normal tiredness."
- 02
Post-exertional malaise (PEM)
Worsening of all symptoms after minimal physical or mental effort. The "crash" can begin 12-72 hours after the activity and last days to weeks. It is the most specific symptom of ME/CFS.
- 03
Unrefreshing sleep
Regardless of duration, sleep does not restore energy. Patients wake as tired or more tired than when they lay down. Sleep architecture changes are common.
- 04
Cognitive dysfunction ("brain fog")
Difficulty with short-term memory, concentration, information processing, word-finding. Can be as disabling as fatigue itself. Worsens with cognitive exertion.
- 05
Orthostatic intolerance
Symptoms worsen when standing or sitting for prolonged periods. May include postural tachycardia (POTS), dizziness, presyncope, and near-fainting sensations.
- 06
Chronic pain
Diffuse muscle pain, headache (often of a new type), joint pain without inflammation. Pain is variable and may be migratory.
- 07
Sensory hypersensitivity
Intolerance to light, noise, odors, and sensory stimuli in general. Reflects dysregulated central sensory processing.
- 08
Immunological symptoms
Recurrent sore throat, tender lymph nodes, low-grade fever, sensation of "always being sick with flu." Reflect chronic immune activation.
- 09
Autonomic symptoms
Palpitations, body temperature instability, abnormal sweating, gastrointestinal disturbances — all manifestations of dysautonomia.
Diagnosis
ME/CFS diagnosis is clinical, based on established criteria. There is no test that confirms the diagnosis, but extensive testing is necessary to exclude other causes of chronic fatigue — such as hypothyroidism, anemia, diabetes, celiac disease, adrenal insufficiency, and autoimmune diseases.
The most commonly used diagnostic criteria are from the Institute of Medicine (IOM/NAM, 2015), which simplified diagnosis and made it more accessible. The mean time between symptom onset and correct diagnosis is 5-7 years — unacceptably long.
🏥IOM/NAM 2015 Criteria for ME/CFS
Fonte: Institute of Medicine / National Academy of Medicine
Mandatory Criteria (all 3)
All three mandatory criteria must be present- 1.Substantial reduction in the ability to engage in pré-illness activities, with profound fatigue of new onset (not lifelong) for ≥6 months
- 2.Post-exertional malaise (PEM) — symptoms worsen after physical, cognitive, or emotional effort
- 3.Unrefreshing sleep
At Least 1 of 2 Additional Criteria
- 1.Cognitive impairment (memory, concentration, processing problems)
- 2.Orthostatic intolerance (symptoms worsen on standing, postural tachycardia)
DIFFERENTIAL DIAGNOSIS: CAUSES OF CHRONIC FATIGUE
| CONDITION | HOW TO DISTINGUISH | TEST |
|---|---|---|
| Hypothyroidism | Weight gain, bradycardia, constipation — without PEM | TSH, free T4 |
| Anemia | Pallor, exertional dyspnea — fatigue proportional to anemia | CBC, ferritin |
| Diabetes mellitus | Polyuria, polydipsia — fatigue improves with glycemic control | Glycemia, HbA1c |
| Obstructive sleep apnea | Snoring, respiratory pauses, daytime sleepiness | Polysomnography |
| Major depression | Generalized anhedonia, guilt, suicidal ideation — without typical PEM | Psychiatric evaluation (PHQ-9) |
| Celiac disease | Diarrhea, distension, weight loss — improves with diet | Anti-transglutaminase, biopsy |
| Adrenal insufficiency | Hypotension, hyperpigmentation, hypoglycemia | Morning cortisol, ACTH stimulation test |
| Multiple sclerosis | Focal neurological signs, relapses and remissions | Brain and spinal MRI, CSF |
DIFFERENTIAL DIAGNOSIS
Differential Diagnosis
Hypothyroidism
- Fatigue + weight gain + cold intolerance
- Cognitive slowing
- Elevated TSH
Diagnostic Tests
- TSH
- Free T4
Iron-Deficiency Anemia
- Fatigue + pallor + exertional dyspnea
- Low ferritin
- Microcytosis
Diagnostic Tests
- CBC
- Ferritin
Depression
Read more →- Fatigue associated with anhedonia and depressed mood
- Improves with antidepressants
- No post-exertional worsening
Diagnostic Tests
- PHQ-9
- Interview
Sleep Apnea
- Daytime sleepiness
- Snoring
- Waking without feeling rested
Diagnostic Tests
- Polysomnography
Systemic Lupus Erythematosus
- Fatigue + arthralgia + photosensitivity + rash
- Women of reproductive age
Diagnostic Tests
- ANA
- Anti-DNA
- Complement
Treatable Causes of Chronic Fatigue
Before establishing an ME/CFS diagnosis, treatable causes of chronic fatigue should be systematically ruled out. Hypothyroidism is the main one: profound fatigue, psychomotor slowing, weight gain, cold intolerance, dry skin, and constipation. TSH and free T4 are mandatory. Iron-deficiency anemia causes fatigue, pallor, exertional dyspnea, and palpitations — CBC with ferritin, B12, and folate confirm the diagnosis. Vitamin D deficiency may also contribute.
Obstructive sleep apnea causes intense daytime sleepiness, fatigue, and cognitive difficulty that can be confused with ME/CFS. Polysomnography or nocturnal oximetry should be considered, especially in patients with snoring, obesity, or a thick neck. Diabetes and chronic inflammatory diseases (Crohn disease, rheumatoid arthritis) also cause significant fatigue and should be investigated clinically.
Depression and ME/CFS: A Complex Relationship
The distinction between ME/CFS and depression is clinically important and often difficult. Both cause profound fatigue, cognitive difficulty, and sleep disturbances. The central difference lies in post-exertional malaise (PEM) — the cardinal feature of ME/CFS that does not occur in depression. In depression, physical exercise typically improves mood and energy; in ME/CFS, any effort — physical or cognitive — that exceeds the patient’s energy envelope causes significant worsening over the next 12-48 hours.
Depression may be a comorbidity of ME/CFS (reactive to suffering and functional loss) or an alternative diagnosis. The PHQ-9 helps in screening. When depression is the primary diagnosis, antidepressants and psychotherapy improve fatigue; in ME/CFS, antidepressants do not treat the cause and some may worsen symptoms. The distinction has important therapeutic implications.
Autoimmune and Inflammatory Diseases
Systemic lupus erythematosus (SLE) and other autoimmune diseases can cause intense fatigue, diffuse arthralgia, cognitive difficulty ("lupus fog"), and malaise — a picture that may be clinically indistinguishable from ME/CFS. SLE is more common in women of reproductive age (20-40 years). Additional features such as photosensitivity, malar rash, oral ulcers, and alopecia should be investigated. ANA with titer and specificity (anti-DNA, anti-Sm) guides diagnosis.
Primary Sjogren syndrome can also cause severe fatigue, diffuse pain, and "brain fog" without obvious sicca symptoms (dry mouth and eyes). Anti-SSA and anti-SSB are markers. Early-phase multiple sclerosis may present with fatigue as the main symptom. When neurological symptoms are present (diplopia, asymmetric weakness, paresthesias), brain and spinal MRI are indicated.
Treatment
There is no cure for ME/CFS. Treatment is focused on symptom management, prevention of worsening, and maximization of functionality within the limits of the disease. The central strategy is "pacing" — energy management to avoid post-exertional malaise.
It is essential to avoid the "mandatory graded exercise" (GET) approach — recent studies show that progressively increasing physical activity, when done without respecting individual limits, may significantly worsen the symptoms of ME/CFS. Pacing is the approach recommended by current guidelines (NICE 2021).
Pacing: Energy Management
Pacing consists of balancing activity and rest within the patient’s "energy envelope" — the activity limit that can be performed without triggering post-exertional malaise. This requires learning to recognize early signs of exhaustion and stopping before exceeding the limit. Heart rate monitors can help identify this threshold.
SYMPTOMATIC TREATMENT OF ME/CFS
| SYMPTOM | APPROACHES | NOTES |
|---|---|---|
| Fatigue and PEM | Pacing, energy management, activity planning | Avoid boom-bust cycles (excess followed by collapse) |
| Sleep disturbance | Sleep hygiene, melatonin, low-dose trazodone | Avoid long-term hypnotics; sleep does not normalize completely |
| Chronic pain | Pregabalin, duloxetine, low-dose amitriptyline | Simple analgesics generally insufficient; address centrally |
| Orthostatic intolerance | Increased salt and fluids, compression stockings, fludrocortisone | Gradual tilt training may help; avoid dehydration |
| Brain fog | Cognitive pacing, organization tools, stimulants (with caution) | Avoid excessive cognitive effort; respect limits |
| Immunological symptoms | Monitoring, nutritional support | There are no immunomodulators approved for ME/CFS yet |
Initial Phase (1-2 months)
Diagnosis and exclusion of treatable causes. Psychoeducation about pacing. Identifying the energy envelope. Treating insomnia and pain.
Stabilization (2-6 months)
Consistent pacing implementation. Treating dysautonomia if present. Psychological support for adaptation. Nutritional evaluation.
Continued Management
Fine-tuning pacing based on fluctuations. Managing flares. Monitoring comorbidities. Social and occupational support.
Long Term
Lifestyle adaptation. Preventing deterioration. Multidisciplinary follow-up. Participating in clinical research when available.
Acupuncture as Treatment
Acupuncture has been studied as a complementary treatment for ME/CFS, focused on improving fatigue, sleep quality, and chronic pain. The proposed mechanisms are particularly relevant to ME/CFS pathophysiology.
Among the mechanisms proposed in experimental models and clinical studies are modulation of the autonomic nervous system, reduction of pro-inflammatory cytokines, modulation of the immune response, effects on microcirculation, and release of endogenous opioids — without any of these mechanisms being fully established as a single causal pathway. As a clinical effect, acupuncture may contribute to improved sleep quality and reduced chronic pain, two factors that compose the symptom burden.
As a complementary treatment, acupuncture can be integrated into the ME/CFS management plan, respecting pacing principles. Sessions should be adjusted to the patient’s tolerance — excessive stimulation may trigger post-exertional malaise.
Prognosis
The prognosis of ME/CFS is variable. Approximately 5-10% of patients recover completely, while the majority experience chronic fluctuation with better and worse periods. A significant proportion (25%) remains severely disabled.
Factors associated with better prognosis include: young age at onset, short duration before diagnosis, absence of significant comorbidities, and early adequate pacing. Early diagnosis and preventing deterioration (avoiding repeated PEM) are essential.
Ongoing research on biomarkers, immunomodulators, and metabolic therapies offers hope for more effective future treatments. Including ME/CFS in the global research agenda, accelerated by the COVID-19 pandemic, has been a positive development for patients.
Myths and Facts
Myth vs. Fact
Chronic fatigue is just laziness or lack of motivation.
ME/CFS is a documented biological disease with mitochondrial dysfunction, immune dysregulation, dysautonomia, and measurable metabolic changes. Two-day consecutive cardiopulmonary exercise testing shows that ME/CFS patients objectively produce less energy on the second day — something impossible to simulate.
Myth vs. Fact
Progressive physical exercise is the solution for chronic fatigue.
Graded exercise therapy (GET) was abandoned by the 2021 NICE guidelines due to risk of harm. Post-exertional malaise in ME/CFS is a real pathological response — distinct from deconditioning. Pacing (energy management) is the currently recommended approach.
Myth vs. Fact
If the tests are normal, the patient has nothing.
ME/CFS is not diagnosed by conventional tests — these serve to rule out other causes. Research tests (metabolomics, two-day cardiopulmonary test, tilt table) show objective abnormalities. The absence of findings on routine tests does not mean the absence of disease.
When to Seek Help
If you are experiencing profound fatigue that does not improve with rest and worsens after effort, seek medical evaluation. The earlier the diagnosis and implementation of pacing, the better the prognosis.
Frequently Asked Questions about Chronic Fatigue Syndrome
Chronic Fatigue Syndrome (CFS), now called Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), is a complex neuroimmunological disease marked by severe, disabling fatigue lasting 6 months or more that does not improve with rest and worsens with any activity (post-exertional malaise). It also involves cognitive dysfunction and orthostatic intolerance. It is not laziness or a psychosomatic condition — it has documented neurobiological and immunological bases, often triggered by viral infections.
Post-exertional malaise (PEM) is the cardinal symptom of ME/CFS — without it, the diagnosis does not stand. It consists of significant worsening of all symptoms — fatigue, pain, cognitive difficulty — in response to any activity (physical or mental) that exceeds the patient’s "energy envelope." PEM usually occurs 12-48 hours after the effort and may last days or weeks. Unlike normal fatigue, it does not improve with rest proportional to the effort.
Diagnosis is clinical, based on the Institute of Medicine (2015) criteria — it requires three mandatory features: (1) substantial fatigue for 6+ months that does not improve with rest and is new (not pré-existing); (2) post-exertional malaise; (3) unrefreshing sleep. Plus at least one of two additional features: cognitive impairment or orthostatic intolerance. There is no specific laboratory test — tests are ordered to rule out other causes. Correct diagnosis often takes years.
It worsens it, in ME/CFS — this is a critical point that differentiates it from most other fatigue conditions. Graded exercise (GET), previously recommended, is now contraindicated by most updated guidelines (including NHS and CDC) because it can trigger severe PEM and worsen the disease permanently. The correct strategy is "pacing" — staying within the individual energy envelope, without exceeding the anaerobic threshold. This is fundamentally different from the approach for depression or fibromyalgia.
Emerging evidence suggests acupuncture can improve fatigue, sleep quality, and quality of life in ME/CFS, with a favorable safety profile. The proposed mechanism involves immune modulation (regulating pro-inflammatory cytokines), improved autonomic function, pain reduction, and better sleep. The approach should be cautious — shorter initial sessions and close monitoring, since excessive stimulation may trigger PEM. The medical acupuncturist should have experience with ME/CFS.
Yes, the relationship is very close. A significant proportion of patients with long COVID present a syndrome that meets criteria for ME/CFS — with post-exertional malaise, severe fatigue, cognitive dysfunction ("brain fog"), autonomic dysfunction, and orthostatic intolerance. COVID-19 appears to be a potent trigger for ME/CFS in predisposed individuals, as do other viral infections (EBV, enteroviruses). The increase in long COVID cases has accelerated research in ME/CFS.
There is currently no cure for ME/CFS. In children and adolescents, partial or complete recovery is more likely over the years. In adults, prognosis is variable — some achieve significant improvement with adequate management; others remain on a chronic, disabling course. Pacing (energy management) is the intervention with the strongest consensus of benefit. Research is advancing rapidly and treatments targeting the pathophysiology (immune dysfunction, microbiome, cellular metabolism) are under study.
The initial panel should include: complete blood count, ESR, CRP; thyroid function (TSH, free T4); fasting glucose; ferritin, B12, folic acid; vitamin D; renal and hepatic function; routine urinalysis; ANA for autoimmunity screening; and EBV and CMV serology (if post-infectious onset). Polysomnography if apnea is suspected. These tests rule out treatable causes — in ME/CFS, routine tests are normal. Specialized tests (orthostatic tilt test, post-exertion lactate) may be needed in selected cases.
Orthostatic intolerance is the inability to tolerate an upright position for prolonged periods. In ME/CFS, it manifests as dizziness, palpitations, blurred vision, and worsening fatigue and cognition after standing for more than a few minutes — improving when lying down. The most studied form is Postural Tachycardia Syndrome (POTS), with a heart rate increase >30 bpm on standing. Increased hydration, dietary salt, compression stockings, and specific medications may help.
Seek medical evaluation if: fatigue persists for 4 weeks or more without obvious explanation; tiredness does not improve with adequate rest; there is worsening of fatigue after activities previously tolerated; there is persistent cognitive difficulty ("brain fog"); or if fatigue is compromising work or daily activities. The initial investigation looks for treatable causes. A correct diagnosis prevents both undertreatment (not treating an identifiable cause) and overtreatment with harmful therapies (such as graded exercise in true ME/CFS).
Related Reading
Deepen your knowledge with related articles